We have a window of opportunity with the media anxious to do stories on COVID treatments and monoclonal antibodies in particular. A small PR effort right now will get far more bang for the buck.

We can get our M/M results out and get the LL name out. Trial enrollment will increase. This window is open NOW but for how long?

I would love to see Dr Kelly doing an interview on any major network. That is what I thought Melissa Dodd would do for us. Just use her contacts to arrange an interview. I guess once again I was misled.